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Altering bioelectricity on inhibition 
of human breast cancer cells
Seher Berzingi1†, Mackenzie Newman2† and Han‑Gang Yu2* 
Abstract 
Background: Membrane depolarization is associated with breast cancer. Depolarization‑activated voltage‑gated ion 
channels are directly implicated in the initiation, proliferation, and metastasis of breast cancer.
Methods: In this study, the role of voltage‑gated potassium and calcium ion channel modulation was 
explored in two different invasive ductal human carcinoma cell lines, MDA‑MB‑231 (triple‑negative) and MCF7 
(estrogen‑receptor‑positive).
Results: Resting membrane potential is more depolarized in MCF7 and MDA‑MB‑231 cells compared to normal 
human mammary epithelial cells. Increasing extracellular potassium concentration up to 50 mM depolarized mem‑
brane potential and greatly increased cell growth. Tetraethylammonium (TEA), a non‑specific blocker of voltage‑
gated potassium channels, stimulated growth of MCF7 cells (control group grew by 201 %, 1 mM TEA group grew 
376 %). Depolarization‑induced calcium influx was hypothesized as a requirement for growth of human breast cancer. 
Removing calcium from culture medium stopped growth of MDA and MCF7 cells, leading to cell death after 1 week. 
Verapamil, a blocker of voltage‑gated calcium channels clinically used in treating hypertension and coronary disease, 
inhibited growth of MDA cells at low concentration (10–20 μM) by 73 and 92 % after 1 and 2 days, respectively. At 
high concentration (100 μM), verapamil killed >90 % of MDA and MCF7 cells after 1 day. Immunoblotting experiments 
demonstrated that an increased expression of caspase‑3, critical in apoptosis signaling, positively correlated with 
verapamil concentration in MDA cells. In MCF7, caspase‑9 expression is increased in response to verapamil.
Conclusions: Our results support our hypotheses that membrane depolarization and depolarization‑induced 
calcium influx stimulate proliferation of human breast cancer cells, independently of cancer subtypes. The underlying 
mechanism of verapamil‑induced cell death involves different caspases in MCF7 and MDA‑MB‑231. These data sug‑
gest that voltage‑gated potassium and calcium channels may be putative targets for pharmaceutical remediation in 
human invasive ductal carcinomas.
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Background
Breast cancer is a leading cancer in women. In 2015, 
231,840 new cases of female invasive cases were diag-
nosed in the US (American Cancer Society, Surveillance 
Research, 2015). Traditionally, there are three clini-
cal subtypes of breast cancer: estrogen or progesterone 
receptor-positive (ER+ or PR+), human epidermal 
growth factor receptor 2 positive (HER2+), and triple 
negative (ER−, PR−, HER2−). Recently, based on genetic 
profiling, revised clinical classifications suggested five 
subtypes: luminal A, luminal B, basal, claudin-low, and 
HER2 [1].
Invasive ductal carcinoma (IDC) is the most preva-
lent type of breast cancer. For this study, we chose 
to use MCF7 (ER+, PR+, or luminal A) and MDA-
MB-231 (triple-negative or claudin-low) cells due to 
their prevalence in contemporary cancer research, 
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well-defined characteristics, and similarity to in  vivo 
IDC development when cultured. These two cell lines, 
along with T-47D, account for over two-thirds of all 
abstracts on breast cancer growth studies [2]. The 
MCF7 cell line has become the most widely-used breast 
cancer line since its establishment in 1973. MDA-
MB-231 cells exhibit a more aggressive phenotype in 
contrast to MCF7 cells [3] and are therefore a model of 
intractable IDC.
Bioelectrical potentials depend on ion flux in biological 
cells. Due to an asymmetrical distribution of ions across 
the plasma membrane, ions constantly flow in and out of 
cell membranes through their transporters: ion channels, 
pumps and exchangers [4]. Gating of ion channels results 
in changes in resting membrane potential which is essen-
tial for both normal cell and cancer development [4]. The 
roles of voltage-gated calcium channels, sodium chan-
nels, and potassium channels in cancer cell proliferation, 
invasion, and metastasis have only recently been demon-
strated [4–9].
Breast cancer cells isolated from patients have a rest-
ing membrane potential of −13  mV [10]. In normal 
human mammary epithelial cells (HMEC), the rest-
ing membrane potential is −60  mV [10]. Membrane 
depolarization has been hypothesized to stimulate cell 
proliferation [4]. Membrane depolarization activates 
voltage-gated calcium channels and causes an influx of 
Ca2+ through T-type voltage-gated calcium channels in 
human breast cancer cells [11]. Calcium channels play a 
pivotal role in proliferation and tumorigenesis of the cell, 
yet the underlying mechanism is not completely under-
stood [12]. T-type voltage-gated calcium channels have 
been reported to be overexpressed in MCF7 and play an 
important role in cell proliferation [13]. Potassium chan-
nel blockers such as 4-aminopyridine mimic the effects of 
calcium channel activators and provide an influx of cal-
cium into the cell [14].
Calcium-triggered apoptosis is a principle pathway that 
regulates cell growth and death [15]. Apoptosis is mainly 
but not exclusively triggered by caspases [16]. Breast can-
cer cells express various isoforms of caspases. Caspase-3 
is present in MDA-MB-231, but not in MCF7 cells [17], 
which express other isoforms such as caspase-9 [18, 19].
To test the hypothesis that altered bioelectricity in 
cell membranes may be independent of breast cancer 
subtypes, we investigated the effects of voltage-gated 
potassium and calcium channel blockers on prolifera-
tion of two different breast cancer cell lines, MCF7 and 
MDA-MB-231. Particularly, we focused on cell death 
induced by verapamil, a clinically used calcium channel 




Human breast adenocarcinoma cells (ER-positive MCF7 
and triple-negative MDA-MB-231) were routinely cul-
tured in Dulbecco’s modified eagle’s medium (DMEM, 
invitrogen) containing 10 % fetal bovine serum, 100 IU/
mL penicillin, and 100 g/L streptomycin. Normal HMEC 
(ATCC) were grown in mammary epithelial cell basal 
medium (MEC), supplemented with MEC growth kit 
(ATCC). Cells were washed with PBS and media was 
replaced daily until 90  % confluence was reached. After 
addition of TEA or verapamil, cells were monitored every 
24 h for cell growth and death.
Whole‑cell patch clamp measurement of resting 
membrane potential
For resting membrane potential measurement using 
whole-cell patch clamp technique, cells were trans-
ferred to polylysine-coated coverslips. These were placed 
in a lucite bath with the temperature maintained at 
35–37 °C using a temperature control unit (TC2BIP, Cell 
MicroControls). Resting membrane potential (Em) was 
recorded using the whole cell patch clamp technique 
with an Axopatch–700B amplifier. Em was measured with 
normal Tyrode’s and pipette solutions. The Tyrode’s solu-
tion contained (in mM): 143 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 
MgCl2, 0.25 NaH2PO4, and 5 HEPES; pH was adjusted to 
7.4 by NaOH. The pipette solution contained (in mM): 
120 KCl, 1 CaCl2, 5 MgCl2, 5 Na2ATP, 11 EGTA, 10 
HEPES, and 11 glucose; pH was adjusted to 7.3 by KOH.
Live cell imaging
Cells in 6-well plates were imaged daily using a Zeiss 
fluorescent microscope equipped with an AxioCam HRc 
camera and AxioVision 4.6 imaging software.
Quantification of cells using ImageJ
Fiji ImageJ was used for cell quantification. The image 
threshold range was set manually for all images using the 
‘Dark Background’ setting. When using the ‘Analyze Par-
ticles’ plugin, a minimum size value of 0.001 pixels2 was 
set to prevent miscounting cell debris as live cells.
Immunoblotting
Protein extracts were prepared after 90  % death was 
observed. Floating cells were pelleted from the media by 
centrifugation (3000×g for 5 min) and then resuspended 
in lysis buffer (fresh protease and phosphatase inhibitors 
(Sigma), 20 mM Tris, 150 mM NaCl, 10 mM EGTA and 
10 mM EDTA at pH 7.4). Buffer was then added to cul-
ture dishes and a cell scraper was used to detach cells. 
The dishes were allowed to sit for 5  min before cellular 
debris was centrifuged out of solution. Supernatants 
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were placed into new tubes and protein concentrations 
were recorded using Bradford’s method on an Eppendorf 
biophotometer.
For western blotting procedures, protein concentra-
tions were normalized between samples to 20  μg and 
mixed with non-reducing lane marker (Thermo Fisher) 
with 5  % β-mercaptoethanol. After heating in a water 
bath to 95 °C for 5 min, samples were cooled to 4 °C then 
loaded into a 4–12  % bis–tris gels (invitrogen). Electro-
phoresis was carried out at 80 V for 30 min then 160 V 
for the remainder.
Proteins were transferred to pre-wetted nitrocellu-
lose membranes (0.2 μm pore size) at 30 V for 1 h. Blots 
were blocked with 3  % bovine serum albumin (BSA) in 
tris-buffered saline with 0.1 % tween-20 (TBS-T) for 1 h 
before primary caspase-3 or caspase-9 antibody (1:1000 
dilution; cell signaling) was added on a shaker at 4  °C 
overnight. Primary antibody solution was replaced with 
fresh 3  % BSA in TBS-T containing secondary antibod-
ies at 1:10,000 dilution for 1 h at room temperature on a 
shaker. After five washes with TBS-T, blots were devel-
oped with a standard ECL kit (Life Technologies) on x-ray 
film or using a G:BOX digital imaging system (Syngene).
Statistical analysis
Data were presented as mean ± SEM. Student’s t test was 
used to calculate the statistical significance between two 
groups. ANOVA was used to calculate the statistical sig-
nificance among multiple groups. Data were considered 
as statistically significant when p < 0.05.
Results
Bioelectricity and cell growth of normal and tumor 
mammary epithelial cells
Figure  1a compares the resting membrane poten-
tial (Em) in HMEC, MCF7, and MDA-MB-231 cells. 
MCF7 cells are 30.4  mV more depolarized in com-
parison to HMEC cells (Em_MCF7 = −36.5 ±  5.4  mV, 
Em_HMEC = −66.9 ± 4.4 mV, n = 8, p < 0.005). MDA-
MB-231 cells are 27.3  mV more positive compared to 
HMEC (Em_MDA-MB-231  =  −39.5  ±  5.4  mV, Em_
HMEC = −66.9 ± 4.4 mV, n = 8, p < 0.001). HMEC at 
days 1 and 5 are shown in Fig.  1b and c, respectively. 
Compared to day 1, cells grew 1.47 ± 0.16-fold in HMEC 
(n  =  4, p  <  0.05), 10.33  ±  2.19-fold in MCF7 (n  =  4, 
p < 0.05), and 19.93 ± 3.83-fold in MDA-MB-231 (n = 4, 
p < 0.05) (Fig. 1d).
Stimulation of breast cancer cell growth by membrane 
depolarization
The normal potassium concentration in standard cell 
culture medium (DMEM) is 5  mM. Altering potassium 
concentration in DMEM changes membrane potential, 
which affected growth of MDA-MB-231 cells (Fig. 2). We 
started cell culture with approximately the same number 
of cells on day 1 under different potassium concentra-
tions (Fig. 2a, 5 mM, Fig. 2c, 50 mM). After 5 days, cells 
grew significantly more in culture containing 50 mM K+ 
ions (Fig.  2d) than in culture containing 5  mM  K+ 
(Fig.  2c). On average, the growth rate was increased by 
1.89 ± 0.07-fold in 50 mM K+ medium than in 5 mM K+ 
medium (growth rate was normalized to 5 mM K+, n = 3, 
p < 0.01) after 5 days of culture (Fig. 2e).
Voltage-gated potassium channels control the plasma 
membrane potential and blocking these channels induces 
membrane depolarization [20]. We used a non-selective 
potassium channel blocker, TEA, to study the effect of 
depolarization on growth of MCF7 cells. In the absence 
of TEA, cells grew 225 % after 4 days in culture (Fig. 3a, 
b) (n =  128.2 ±  12 at day 0, n =  416.7 ±  22 at day 4, 
p < 0.01, n = 3). In the presence of 1 mM TEA, cells grew 
4.78 ± 0.50 fold at day 4 compared to day 0 (normalized) 
(Fig.  3c–e, n =  3, p  <  0.01). These results indicate that 
changes in membrane potential have significant effects 
on growth rate of breast cancer cells.
Calcium as a key modulator in breast cancer cell growth
To understand how depolarized membranes can stimu-
late growth of breast cancer cells, we studied the effect 
of calcium ions on cell proliferation. After 5 days, MCF7 
cells barely grew in the absence of Ca2+ ions in the cul-
ture medium (Fig.  4b) compared with cells growing to 
nearly 100 % confluence in medium that contains 2 mM 
Ca2+ ions (Fig.  4a). The average cell population growth 
in the absence and presence of Ca2+ ions is shown in 4C 
for MCF7 and in 4D for MDA-MB-231, respectively. Cell 
numbers at day 1 were normalized (Fig. 4c, d). In normal 
DMEM containing Ca2+, MCF7 cells grew 2.5 ±  0.07-
fold at day 2, 4.56 ±  0.13 at day 3, 9.55 ±  0.28-fold at 
day 4, 20.78 ± 0.60-fold at day 5, and 34.83 ± 1.01-fold at 
day 6; and MDA-MB-231 cells grew 2.03 ±  0.06-fold at 
day 2, 3.87 ± 0.11-fold at day 3, 7.66 ± 0.22-fold at day 4, 
13.71 ± 0.40-fold at day 6, and 19.93 ± 0.58-fold at day 6. 
In the absence of external Ca2+, cells barely grew (Fig. 4c, 
dark bars) or grew in a significantly slower rate compared 
to that with Ca2+ (Fig. 4d, dark bars). These results indi-
cate the essential requirement of external Ca2+ ions dur-
ing growth of breast cancer cells.
External Ca2+ ions can be blocked from entering the 
cell specifically through voltage-gated calcium channels 
[11] with verapamil. Figure 5a shows MDA-MB-231 cells 
grown in normal medium without verapamil. After 1 day 
of incubation with 10 μM verapamil, cell number dramati-
cally decreased (Fig.  5b). Figure  5c shows the growth of 
MDA-MB-231 cells at day 2 and 3 under different con-
centrations of verapamil. Compared to the absence of 
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verapamil (0  μM), verapamil inhibited cell growth by 
74  % at 10  μM and 92  % at 20  μM, respectively (n =  3, 
p < 0.01). Figure 5d shows inhibited growth of MCF7 cells 
by verapamil. At day 3, verapamil inhibited cell growth 
by 49 % at 10 μM and 85 % at 20 μM, respectively (n = 3, 
p < 0.05).
Fig. 1 Bioelectricity and cell growth. a Resting membrane potential (Em) in HMEC, MCF7, and MDA‑MB‑231, n = 10 for each group. b HMEC at 
day 1. c HMEC at day 5. d Cell growth at day 5 compared to day 1 (normalized) for HMEC, MCF7, and MDA‑MB‑231. n = 4 for each group. FC fold 
change. Asterisk indicates statistical significance
Fig. 2 Effect of increased K+ concentration on MDA‑MB‑231 cell growth. MDA‑MB‑231 cell growth in the presence of 5 mM K+ at day 1 (a) and day 
6 (b), and in the presence of 50 mM K+ at day 1 (c) and day 6 (d). Averaged cell growth of MDA‑MB‑231 cell populations in different concentrations 
of K+ (E). FC fold change. Asterisk indicates statistical significance
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Mechanism of verapamil‑induced death in breast cancer 
cells
One common cellular mechanism associated with 
calcium in cell death is the caspase signaling pathway 
[15]. Among the many caspases in breast cancer cells, we 
focused on caspase-3 not only because it is the principle 
Fig. 3 Effect of TEA on MCF7 cell growth. MCF7 cell growth in the presence of 1 mM TEA at day 0 (a) and day 4 (b), and in the presence of 1 mM 
TEA at day 0 (c) and day 4 (d) of growth. Averaged cell growth of MCF7 cells with 1 mM TEA at days 0 and 0 (e). FC fold change
Fig. 4 Effect of Ca2+ on MCF7 and MDA‑MB‑231 cell growth. MCF7 cell growth in the presence of Ca2+ (a) and in the absence of Ca2+ (b). Aver‑
aged cell growth of MCF7 (c) and MDA‑MB‑231 (d) in the absence and presence of Ca2+. FC fold change
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caspase in caspase family [21], but also since it is present 
in MDA-MB-231 but not in MCF7 cells [17].
Figure  6 shows the representative western blots for 
caspase levels in MCF7 and MDA-MB-231 cells. The 
levels of protein expression of caspase-3 were increased 
by verapamil in a concentration-dependent manner in 
MDA-MB-231, whereas no caspase-3 protein expres-
sion was detected in MCF7 cells (Fig.  6a). In compari-
son to the absence of verapamil, α-actin normalized 
caspase-3 levels are increased by 28-fold in 10 μM vera-
pamil (0  μM  =  0.026  ±  0.007, 10  μM  =  0.72  ±  0.19, 
n  =  3, p  <  0.05) and 45-fold in 20  μM verapamil 
(0  μM =  0.026 ±  0.007, 20  μM =  1.16 ±  0.04, n =  3, 
p  <  0.001) (Fig.  6b). In MCF7 cells the caspase-9 levels 
are increased after verapamil treatment (Fig. 6c). In com-
parison to the absence of verapamil, α-actin normalized 
caspase-9 levels are increased by 1.9-fold in 10 μM vera-
pamil (0 μM = 0.42 ± 0.12, 10 μM = 0.79 ± 0.20, n = 3), 
but insignificantly (p > 0.05), and 2.6-fold in 20 μM vera-
pamil (0 μM = 0.42 ± 0.12, 20 μM = 1.11 ± 0.19, n = 3, 
p < 0.05) (Fig. 6d).
Discussion
Depolarized membrane potential has recently been rec-
ognized as a potential novel bioelectrical marker of can-
cer cells [22, 23]. In this study, we explored the notion 
that the intrinsic association of membrane potential and 
breast cancer growth is independent of breast cancer 
subtypes. We tested the idea using two different types 
of human breast cancer cell lines, an ER+ MCF7 and a 
triple-negative MDA-MB-231. We attempted to address 
a specific question: if membrane depolarization is indeed 
associated with cell growth of breast cancer cells, what 
mediates the membrane depolarization and proliferation 
of breast cancer cells? Alterations of ion channel expres-
sion and activities are associated with the initiation, 
proliferation, and metastasis of cancer cells [5, 8]. Volt-
age-gated calcium channels are present in human breast 
cancer cells but not in normal human mammary epi-
thelial cells [13]. Therefore, we focused on voltage-gated 
potassium and calcium channels as potential underly-
ing mechanisms that link membrane depolarization and 
breast cancer growth.
Fig. 5 Effect of verapamil on MCF7 and MDA‑MB‑231 cell growth. MDA‑MB‑231 cell growth in the presence of 10 μM verapamil at day 5 (a) and 
day 6 (b). Verapamil was added on day 5. Averaged cell growth of MDA‑MB‑231 (c) and MCF7 (d) for different concentrations of verapamil. Growth 
rate was normalized at 0 μM verapamil. FC fold change
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We showed that membrane potentials of MCF7 and 
MDA-MB-231 are depolarized in comparison to that of 
normal human mammary epithelial cells. HMEC grew 
much slower compared to MCF7 and MDA-MB-231. 
These results are consistent with previous reports that 
demonstrated the association between membrane poten-
tial and breast cancer patients [10].
Second, we showed that membrane depolarization, 
induced by increasing external potassium concentration 
or blocking voltage-gated potassium channels, stimu-
lated growth of MCF7 and MDA-MB-231 cells. Third, 
we demonstrated that calcium is essential for growth 
of MCF7 and MDA-MB-231 since removing exter-
nal calcium led to death of both types of cells. These 
results are consistent with the essential role of calcium 
in cell growth and cancer development [24]. Fourth, we 
observed reduced proliferation and death of MCF7 and 
MDA-MB-231 cells by verapamil, reinforcing the role of 
calcium entry through voltage-gated calcium channels 
during the growth of breast cancer cells. We noticed that 
verapamil inhibited growth of MDA-MB-231 to the simi-
lar degree at days 2 and 3 (Fig. 4c), but it appears there is 
time-dependent inhibition of verapamil on cell growth of 
MCF7 (Fig. 4d).
To understand the underlying mechanisms of vera-
pamil-induced cell death in breast cancer cells, we 
explored the potential role of caspase signaling, known to 
be integral in calcium- induced apoptosis [15]. We found 
that the caspase-3 levels in MDA-MB-231 cells were sig-
nificantly increased during chronic exposure to verapamil. 
In MCF7, no protein expression of caspase-3 was detected 
(Fig. 6a). Rather, caspase-9 protein levels are increased in 
response to verapamil treatment (Fig. 6c). It is imperative 
to emphasize that caspase-9 may not be the main mech-
anism that mediates the apoptotic effect of verapamil 
on MCF7, since the increase in its protein levels is small 
(Fig. 6d) compared to verapamil-induced increase in cas-
pase-3 in MDA-MB-231 (Fig.  6b). Other caspases, such 
as caspase-6 and caspase-7, might be more important 
in mediating the verapamil-induced cell death in MCF7 
[18, 19]. Additionally, there exists caspase-independent 
apoptosis in both MCF7 and MDA-MB-231 cells [25–27]. 
Therefore, the exact mechanisms that mediate verapamil-
induced apoptosis require more investigation.
Fig. 6 Verapamil‑induced caspase expression in MCF7 and MDA‑MB‑231. Representative caspase immunoblots of MDA‑MB‑231 and MCF7 cells 
under different concentrations (0, 10, and 20 μM) of verapamil. a Caspase‑3 expressed in MDA‑MB‑231 but not in MCF7 cells. b Verapamil concen‑
tration‑dependent expression levels of caspase‑3 in MDA‑MB‑231. c Caspase‑9 expression in MCF7 cells. d Verapamil concentration‑dependent 
expression levels of caspase‑9 in MCF7. Alpha‑actin was used as a loading control. Asterisk indicates statistical significance
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A recent study demonstrated that depolarized mem-
brane potential increases the clustering of phosphati-
dylserine lipids and K-Ras, promoting RAF-MAPK 
signaling, which is known to induce proliferation of can-
cer cells [22, 28, 29]. This mechanism has yet to be vali-
dated with regard to intracellular calcium homeostasis in 
the breast cancer cell culture models used in our study.
Conclusions
Collectively, we showed that membrane potential depo-
larization occurs in breast cancer cells, independent 
of subtypes. Verapamil, a voltage-gated calcium chan-
nel blocker which is clinically used to treat hypertensive 
patients can induce cell death in both MCF7 and MDA-
MB-231. However, cellular mechanisms that mediate 
verapamil-induced inhibition of breast cancer cells are 
different and likely subtype-specific.
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